CMECMEFinancial Services · Financial Data & Stock Exchanges

CME Stock Forecast: CME Group, Inc. Price Predictions for 2026-2027

Last close, 17 Nov 2026
$312
−2.45% on the day

The 17 Wall Street analysts covering CME Group, Inc. hold a median 12-month price target of $329 — +5.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 84 of 100 as at 17 Nov 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$113.8B
Ticker Nerd rank
84/ 100
Median analyst target
$329
Analysts covering
17
Revenue$1.7B+0.8% y/y
Operating income$1.1B
Net income$1.0B
Free cash flow$923.5M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+0.8%
1M
+6.0%
YTD
+18.0%
1Y
+15.9%
From 52W high
−2.4%
From 52W low
+43.2%
$218
$319
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

CME stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores CME Group, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 17 Nov 2026
84/ 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility
99
Revisions
87
Momentum
82
Quality
73
Growth
72
Issuance
70
Value
69
Accruals
40
Size
2

Volatility (99): The share price has been relatively steady.

Accruals (40): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.

Size (2): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

CME stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CME, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$200$250$300$350Jan 26Apr 26Jul 26Oct 26CMEHigh $367Median $329Low $227

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says17 analysts
9 Buy6 Hold2 Sell
Low $227Median $329High $367

The green dot is the last close — the median target sits +5.4% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 10 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
22 Oct 2026BarclaysMaintainsEqual-Weight$281 → $321
22 Oct 2026JP MorganUpgradeOverweight$367
22 Oct 2026Morgan StanleyMaintainsOverweight$337 → $359
22 Oct 2026Piper SandlerReiteratesOverweight$295 → $330
22 Oct 2026UBSMaintainsNeutral$270 → $310
22 Oct 2026Wells FargoMaintainsOverweight$315 → $333
14 Oct 2026Wells FargoMaintainsOverweight$301 → $315
14 Oct 2026Wells FargoMaintainsOverweight—
9 Oct 2026Morgan StanleyMaintainsOverweight$330 → $337
9 Oct 2026Morgan StanleyMaintainsOverweight—
7 Oct 2026BarclaysMaintainsEqual-Weight$270 → $281
7 Oct 2026BarclaysMaintainsEqual-Weight—
5 Oct 2026TD CowenMaintainsBuy$292 → $300
5 Oct 2026TD CowenMaintainsBuy—
5 Oct 2026UBSMaintainsNeutral$260 → $270
5 Oct 2026UBSMaintainsNeutral—
2 Oct 2026Wells FargoInitiatesOverweight$301
2 Oct 2026Wells FargoInitiatesOverweight—
28 Sept 2026TD CowenReiteratesBuy—
28 Sept 2026TD CowenReiteratesBuy$292

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

CME appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

CME vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 17 Nov 2026, CME Group, Inc. returned +15.9% against +11.2% for the S&P 500, dividends included.

CME vs S&P 500, last 12 monthsTotal return, rebased to 100
8090100110120Jan 26Apr 26Jul 26Oct 26CMES&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

CME analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
EPS revision, 90 days
+1.1%
Analysts raising
13
Analysts cutting
1
Fundamentals

CME Group, Inc. (CME) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
26.1×

Cheaper than 28% of US stocks

Price / sales
16.4×

Cheaper than 9% of US stocks

Price / book
4.3×

Cheaper than 22% of US stocks

EV / EBITDA
23.3×

Cheaper than 11% of US stocks

Growth & margins
Revenue growth (YoY)
13.0%

Higher than 60% of US stocks

Earnings growth (YoY)
14.2%

Higher than 54% of US stocks

Gross margin
86.3%

Higher than 95% of US stocks

Operating margin
66.2%

Higher than 99% of US stocks

Net margin
63.5%

Higher than 97% of US stocks

Returns & dividend
Return on equity
16.1%

Higher than 76% of US stocks

Return on assets
1.5%

Higher than 55% of US stocks

Dividend yield
1.6%

Higher than 76% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

CME Group, Inc. (CME) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • CME Group, Inc. has a market value of $113.8B and an enterprise value of $115.3B.

  • Revenue in the twelve months to 30 June 2026: $6.8B. The latest quarter grew 13.0% year on year.

  • Net income over the same four quarters: $4.3B, a 63.3% net margin.

  • Diluted earnings per share, trailing twelve months: $11.79.

  • Free cash flow in the twelve months to 30 June 2026: $4.2B.

  • CME Group, Inc. spent $1.5B on share buybacks and $4.1B on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 359,275.

  • Trailing P/E: 26.1×; forward P/E: 24.0× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 1.64%, paying out 93% of earnings.

  • CME Group, Inc. employs 3,875 people — $1.7M of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 14 Nov 2026

Data provided by Twelve Data

Peers

CME vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelFinancial Data & Stock Exchanges
CompanyMarket capTKN rank
CMECME Group, Inc.$113.8B84
ICEIntercontinental Exchange, Inc.$96.2B71
SPGIS&P Global, Inc.$133.4B62
MCOMoody's Corp.$86.4B65
NDAQNasdaq, Inc.$58.3B94
MSCIMSCI, Inc.$46.8B64
CBOECboe Global Markets, Inc.$38.7B93

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own CME Group, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest CME news & analysis

CME vs. Toast: Which Financial Stock Is a Better Buy for 2027?

The Motley Fool · 17 Nov 2026neutral

The Motley Fool compares CME Group and Toast, noting CME’s dominant position in global derivatives and exceptionally high net margins, while Toast is expanding its restaurant technology ecosystem and has recently achieved consistent profitability.

Why it matters — The comparison highlights CME’s market position and margins alongside Toast’s growth and profitability as points of distinction for investors following CME.

CME vs. Morningstar: Which Financial Stock Is a Better Buy for 2027?

The Motley Fool · 16 Nov 2026positive

The Motley Fool compares CME Group and Morningstar, describing CME’s position in the global derivatives market, strong net margin, and technology partnership with Alphabet, alongside Morningstar’s brand authority and diversified customer base.

Why it matters — The comparison highlights CME’s business strengths relative to a financial-data and research company.

CME Group: Dividend Growth Investors Shouldn't Ignore This Stock

Seeking Alpha · 14 Nov 2026positive

A Seeking Alpha article highlights CME Group’s market position, record trading volumes, market-data expansion, and dividend growth. It also points to liquidity advantages, high switching costs, diversified asset classes, strong margins, and disciplined capital allocation.

Why it matters — The article links CME’s competitive position and business growth to its cash returns to shareholders.

CME vs. S&P Global: Which Financial Stock Is a Better Buy for 2027?

The Motley Fool · 10 Nov 2026neutral

The Motley Fool compared CME Group and S&P Global, describing CME as operating a leading derivatives marketplace with a net margin exceeding 60%, and S&P Global as providing credit ratings and data analytics for global capital markets.

Why it matters — The comparison highlights CME’s derivatives-marketplace business and stated profitability as context for investors following the company.

CME vs. Nu: Which Financial Stock Is a Better Buy for 2027?

The Motley Fool · 4 Nov 2026positive

The Motley Fool compares CME Group with Nu, noting CME’s dominance in the global derivatives market and industry-leading net margins, while Nu is rapidly expanding its digital banking platform in Latin America with high revenue growth.

Why it matters — The comparison highlights CME’s market position and margins alongside a fast-growing financial-services competitor.

FAQ

Frequently asked questions about CME stock

What is the CME stock price forecast for 2026-2027?

The 17 Wall Street analysts covering CME Group, Inc. have a median 12-month price target of $329, with estimates ranging from $227 to $367. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is CME stock a buy right now?

Of the 17 analysts covering CME Group, Inc., 9 rate it a Buy, 6 a Hold and 2 a Sell. Ticker Nerd's systematic factor model ranks CME Group, Inc. 84 out of 100 across roughly 4,600 US stocks as at 17 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank CME?

As at 17 Nov 2026, CME Group, Inc. ranks 84 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (99 of 100).

Will CME stock go up?

No one can know that. What the data says: the median 12-month target from 17 analysts implies +5.4% from the last close, and Ticker Nerd's factor model ranks CME Group, Inc. 84 out of 100 as at 17 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the CME stock forecast for 2030?

No analyst covering CME Group, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CME are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $227 to $367 over the next 12 months.

How has CME stock performed over the past year?

CME Group, Inc. returned +15.9% over the 12 months to 17 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does CME Group, Inc. do?

CME Group Inc. Class A Common Stock represents ownership in CME Group, a leading global marketplace for derivatives trading and market data services.

What is the latest news on CME?

The most recent item we track (The Motley Fool, 17 Nov 2026): "CME vs. Toast: Which Financial Stock Is a Better Buy for 2027?". The Motley Fool compares CME Group and Toast, noting CME’s dominant position in global derivatives and exceptionally high net margins, while Toast is expanding its restaurant technology ecosystem and has recently achieved consistent profitability.

Company

About CME Group, Inc.

CME Group Inc. Class A Common Stock represents ownership in CME Group, a leading global marketplace for derivatives trading and market data services. CME Group operates a broad range of futures and options contracts across major asset classes, including interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals. Its core businesses also include clearing, settlement, and related market infrastructure that support risk management and price discovery for institutional investors, commercial hedgers, brokers, and other market participants. The company’s exchange and clearing services are widely used by financial firms and corporate users seeking efficient access to standardized, centrally cleared contracts. CME Group Inc. is headquartered in Chicago and is known for its diversified role in global financial markets, where its products help facilitate trading, hedging, and liquidity across multiple asset classes.

CEO Mr. Terrence A. Duffy · 3,875 employees · United States · https://www.cmegroup.com